排序
2023AAP临床实践指南:儿童和青少年肥胖的评估和治疗
CLINICAL PRACTICE GUIDELINE Guidance for the Clinician in Rendering Pediatric CareAmerican Academyof PediatricsDEDICATED TO THE HEALTH OF ALL CHILDRENClinical Practice Guideline fo...
2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]
NENatonalinsutute forHealth and Care ExcellenceNICE贝guidanceTrastuzumab deruxtecanfor treating HER2-positiveunresectable or metastaticbreast cancer after 1 ormore anti-HER2treatme...
2022中国专家共识:应用生物制剂治疗慢性鼻窦炎(英文)
Review ArticleORLORLReceived:October 31,2022D0t10.1159/000529918Accepted:February 22,2023Published online:April 5,2023Chinese Expert Consensus on the Use ofBiologics in Patients wi...
冠心病与阻塞性睡眠呼吸暂停综合征:基于中医“心肺同治”的解读与思考
0一@他-中国实验方剂学杂志中密套验方利季春名Chinese Journal of Experimental Traditional Medical FormulaeISSN1005-9903,CN11-3495/R《中国实验方剂学杂志》网络首发论文题目:冠心病与阻塞...
重复使用医疗器械包装技术专家共识
中华护理杂志2023年3月第58卷第5期消毒供应及感染控制专题【编者按】医院感染控制对保障医务人员、惑者、家属及相关人员安全,控制重大传染病危害程度具有重要作用,消毒供应中心承担医院内各科...
2023AA指南:迷走神经刺激治疗的围术期管理
真Check for updatesAnaesthesia 2023doi:10.1111/anae.16012GuidelinesManagement of vagus nerve stimulation therapy in theperi-operative periodGuidelines from the Association of Anaes...
2023意大利共识声明:儿童和青少年肥胖的治疗
Maffeis et aL Italian Journal of Pediatrics (2023)49:69Italian Journal of Pediatricshttp5/dol.org/10.1186/s13052-023-01458-zREVIEWOpen AccessThe treatment of obesity in childrenand...
2023专家共识声明:亚太地区使用SGLT-2抑制剂的实际考虑
Received:12 February 2023 Revised:22 April 2023Accepted:24 April 2023D0:10.1111/hep.14167NEPHROLOGYREVIEWARTICLEWILEYPractical considerations for the use of SGLT-2 inhibitors in th...
血管紧张素受体-脑啡肽酶抑制剂在慢性肾脏病患者中应用的中国专家共识
中国血液净化2023年4月第22卷第4期Chin J B1 ood Purif,Apri1,2023,Vol.22,No.04●241●·专家共识·血管紧张素受体-脑啡肽酶抑制剂在慢性肾脏病患者中应用的中国专家共识血管素张素受体一脑啡...
2023BSPED共识指南:儿童和青年肾上腺功能不全的急诊和围手术期管理
ReviewEmergency and perioperative management of adrenalOPEN ACCESSinsufficiency in children and young people:BritishSociety for Paediatric Endocrinology and Diabetesconsensus guida...

![2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]-医知素材库](https://cdn.jiaoyuwz.com/2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]-816b7b06b5-pdf-1.webp)
-d7f3e95840-pdf-1.webp)







